AIM success rates are very high. Among patients accepted for treatment and with success rate defined as a 60% to 100% improvement in function and pain, 80% to 90% of AIM patients experience successful outcomes.
Please note: not all patients are candidates for regenerative injection therapy. Only after performing a comprehensive evaluation and diagnostic imaging will our physicians determine and recommend the most effective treatment. A person’s age, health, exercise level, diet, disease level, local microenvironment and other factors contribute to the outcomes and candidacy. Patients will receive one of 3 candidacy grades for non-insurance based treatments: “Excellent,” “Good” or “Undetermined.”